Armodafinil is the enantiopure compound of the wakefulness-promoting agent,or eugeroic, moda-finil . It consists of only the (R)-(−)-enantiomer of the racemic moda-finil. Armoda-finil is produced by the pharmaceutical company Cephalon Inc. and was approved by the U.S. Food and Drug Administration (FDA) in June 2007. In 2016, the FDA granted Mylan rights for the first generic version of Cephalon's Nuvigil to be marketed in the U.S.
Web: www.rawsgear.com
Web: www.rawsgearpharma.com
Email: gear@quality-steroid.com
Skype: +8615711952876
Whatsapp +8615711952876